• Home Study Details

  • Home / Learn / Home Study CE / Home Study Details


Take Each Pill with a Grain of Salt: A Review of Abuse-Deterrent Opioid Formulations and Place in Therapy

Program Type

Monograph

Credits

1 Contact Hour(s)

Release Date

Tuesday, May 10, 2016

Offline Date:

Thursday, October 12, 2017

ACPE Expiration Date

Wednesday, May 1, 2019

Target Audience

Nurse, Pharmacist

Cost

$0.00

  • Overview

    Opioids have been used for their analgesic and sedative properties throughout history; references to medical use of the opium poppy plant can be found dating back to ancient civilizations in Mesopotamia as early as 3000 B.C. With the therapeutic use of opium came struggles with abuse and addiction, prompting the search for safer analgesic agents. Morphine (named for Morpheus, the god of dreams) was isolated in 1806, but was quickly found to have a similar potential for abuse as opium. When heroin was synthesized almost a century later, it was initially touted as a potent analgesic and abuse-free opioid. Needless to say, such claims of low potential for abuse and addiction from morphine and heroin have been thoroughly discredited.

     



    Rating


    Handouts

    Homestudy PDF:   homestudypdf_0798999916054H04.pdf

    Financial Support By

    Maryland Pharmacists Association
  • Nurse

    Describe the trends in opioid abuse and overdose in the United States.
    List the seven types of abuse-deterrent formulations as defined by the FDA.
    Describe the abuse-deterrent properties of commercially available products according to the FDA guidance.
    Select an appropriate candidate for treatment with an abuse-deterrent opioid formulation within a patient case study.


    Pharmacist

    Describe the trends in opioid abuse and overdose in the United States.
    List the seven types of abuse-deterrent formulations as defined by the FDA.
    Describe the abuse-deterrent properties of commercially available products according to the FDA guidance.
    Select an appropriate candidate for treatment with an abuse-deterrent opioid formulation within a patient case study.

  • Activity Type

    Knowledge

    Universal Activity Number

    Nurse 0798-9999-16-054-H04-P

    Pharmacist 0798-9999-16-054-H04-P

    ACPE PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

    In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.


HARDWARE REQUIREMENTS
Standard Windows/Mac System
iPad or iPhone
Minimum screen resolution: 1024x768
Speakers or headphones
 
 


SOFTWARE REQUIREMENTS
Microsoft Edge
Internet Explorer 8.0 or higher
Google Chrome
Safari
Firefox 3.0.3 or higher
Adobe Acrobat Reader


NETWORK REQUIREMENTS
Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection
 
 
 

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

 

©2015 PharmCon, lnc. All Rights Reserved | Terms & Conditions | Privacy PolicyContinuing Education For Healthcare Professionals
Developed By: ITB, Inc.